tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PTHS Stock Latest News

Horizon Technology provides $50M loan facility to Pelthos Therapeutics
The FlyHorizon Technology provides $50M loan facility to Pelthos Therapeutics
2d ago
HRZN
PTHS
Pelthos Therapeutics Secures $50 Million Venture Loan Financing
PremiumCompany Announcements
Pelthos Therapeutics Secures $50 Million Venture Loan Financing
4d ago
8K
PTHS
Pelthos Therapeutics secures up to $50M senior secured term loan
PremiumThe Fly
Pelthos Therapeutics secures up to $50M senior secured term loan
4d ago
HRZN
PTHS
Pelthos Therapeutics Details Q1 2026 Growth Strategy
PremiumCompany Announcements
Pelthos Therapeutics Details Q1 2026 Growth Strategy
5d ago
8K
PTHS
Pelthos Therapeutics: Xeglyze Acquisition and Dermatology Portfolio Drive Multi‑Year Upside and Support Buy Rating
PremiumRatings
Pelthos Therapeutics: Xeglyze Acquisition and Dermatology Portfolio Drive Multi‑Year Upside and Support Buy Rating
12d ago
PTHS
Pelthos Therapeutics acquires Xeglyze topical treatment for $1.8M
PremiumThe FlyPelthos Therapeutics acquires Xeglyze topical treatment for $1.8M
12d ago
PTHS
Pelthos Therapeutics Acquires Global Rights to Xeglyze
Premium
Company Announcements
Pelthos Therapeutics Acquires Global Rights to Xeglyze
15d ago
8K
PTHS
Pelthos Therapeutics Adds Veteran Finance Executive to Board
Premium
Company Announcements
Pelthos Therapeutics Adds Veteran Finance Executive to Board
24d ago
8K
PTHS
Pelthos Therapeutics Concludes 2025 Annual Stockholder Meeting
PremiumCompany Announcements
Pelthos Therapeutics Concludes 2025 Annual Stockholder Meeting
1M ago
8K
PTHS
Pelthos signs benefit manager agreement expanding patient access to ZELSUVMI
PremiumThe Fly
Pelthos signs benefit manager agreement expanding patient access to ZELSUVMI
1M ago
PTHS
Lake Street starts Pelthos with a Buy on ‘category-leader potential’
PremiumThe Fly
Lake Street starts Pelthos with a Buy on ‘category-leader potential’
1M ago
PTHS
Pelthos Therapeutics initiated with a Buy at Lake Street
PremiumThe Fly
Pelthos Therapeutics initiated with a Buy at Lake Street
1M ago
PTHS
Pelthos Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe FlyPelthos Therapeutics initiated with a Buy at H.C. Wainwright
1M ago
PTHS
Pelthos Therapeutics initiated with a Buy at Roth Capital
Premium
The Fly
Pelthos Therapeutics initiated with a Buy at Roth Capital
2M ago
PTHS
Pelthos Therapeutics price target raised to $57 from $50 at Oppenheimer
Premium
The Fly
Pelthos Therapeutics price target raised to $57 from $50 at Oppenheimer
2M ago
PTHS
Pelthos Therapeutics price target raised to $75 from $60 at Alliance Global
PremiumThe Fly
Pelthos Therapeutics price target raised to $75 from $60 at Alliance Global
2M ago
PTHS
Pelthos Therapeutics Reports Promising Q3 2025 Results
PremiumCompany Announcements
Pelthos Therapeutics Reports Promising Q3 2025 Results
2M ago
PTHS
Pelthos Therapeutics Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Pelthos Therapeutics Earnings Call Highlights Growth and Challenges
2M ago
PTHS
Pelthos Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Pelthos Therapeutics Reports Q3 2025 Financial Results
2M ago
8K
PTHS
Pelthos Therapeutics Inc. (PTHS) Q3 Earnings Cheat Sheet
PremiumPre-EarningsPelthos Therapeutics Inc. (PTHS) Q3 Earnings Cheat Sheet
2M ago
PTHS
Pelthos Therapeutics Acquires Xepi and Secures Financing
Premium
Company Announcements
Pelthos Therapeutics Acquires Xepi and Secures Financing
2M ago
8K
PTHS
Pelthos Therapeutics acquires Xepi Cream from Biofrontera, Ferrer
Premium
The Fly
Pelthos Therapeutics acquires Xepi Cream from Biofrontera, Ferrer
2M ago
BFRI
LGND

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >